Comprehensive Neurology Clinic

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Epilepsy3 trials
• Multiple sclerosis2 trials

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Enrolling by invitation1 trial
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Biohaven Therapeutics Ltd.2 trials
• Novartis Pharmaceuticals2 trials
• Engrail Therapeutics INC1 trial

Running trials

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  NCT07225504· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Elliuz Leal

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Biohaven Therapeutics Ltd.· Source

• Active, not recruiting

  Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06309966· Phase 2/3· Biohaven Therapeutics Ltd.· Source

• Active, not recruiting

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

  NCT05147220· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy1 recruiting
• Multiple sclerosis1 recruiting

Closed trials

• Withdrawn

  ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures

  NCT05481905· Phase 2· Engrail Therapeutics INC· Source